A new deep learning model shows promise in detecting and segmenting lung tumors, according to a study published today in ...

The Lung Cancer Genetics Study, a collaboration between lung cancer advocacy organizations, aims to explore the genetics of lung cancer ...

The European Commission (EC) has approved a Marketing Authorization (MA) for Lazcluze (lazertinib), in combination with ...

The clearance of Datroway comes months after the companies narrowed approval plans in lung cancer and opens up a market ...

Molecular oncology is revolutionizing cancer care by using genetic profiling to tailor personalized treatments, improving ...

A new deep learning model shows promise in detecting and segmenting lung tumors, according to a study published today in Radiology ...

Bob Uecker's cause of death has not been revealed, but his family said he had been battling small cell lung cancer since early 2023.

The Lazcluze plus Rybrevant combination could challenge AstraZeneca’s standard-of-care Tagrisso in non-small cell lung cancer ...

Scientists in China have developed a modified virus that causes cancer cells to make sugars normally found in pigs, causing ...

A breakthrough daily pill which doubles the survival time for certain lung cancer patients will now be routinely available on ...

The FDA approved datopotamab deruxtecan-dlnk for treatment of certain patients with advanced breast cancer.The indication ...

Anixa Biosciences CEO Amit Kumar discusses the biotech’s plans for advancing a breast cancer vaccine in 2025. The cancer ...